As part of promoting users experiences on the Msport platform, Msport has introduced a new promotion called the ₵40,000 TRADER GIVEAWAY PROMOTION. This promotion is mainly for users who play the MSPORT TRADER CASINO GAME with real cash or funds from their balance.
- Promotion Name: ₵40,000 TRADER GIVEAWAY PROMOTION
- Promotion Period: 2025/07/07 - 2025/08/03
- How to join: Play the TRADER GAME with real cash or your balance and you can participate in this promotion
- Promotion Rules
-
Daily Free Bets Rewards:
During the promotion period, every bet placed on the TRADER GAME will give you a random chance to win a Free Bet, ranging from GH₵1 to GH₵100. A total of GH₵10,000 will dropped every week.
Free Bets will be distributed through the Msport system using the Free Bet API, and will be automatically credited to the user's Free Bets Account. -
Monday GH₵30,000 Prize Pool
All users who place bets on the TRADER GAME will automatically qualify for next Monday's GH₵30,000 Prize Pool. The Prize Pool breakdown is as follows;
1. GH₵10,000 in Cash: 1 Winner, chosen through a random draw.
2. GH₵5,000 in Cash: 1 Winner, chosen through a random draw.
3. GH₵1,000 in Cash: 5 Winners, chosen through a random draw.
4. Share Extra GH₵10,000: All Trader game users (players who played the game) will equally share this pool prize as Free Bets. -
Prize Distribution:
The prizes would be distributed before every Wednesday after a round end. Cash prizes will be credited to user's balance directly. Free Bets prizes distributed can be found in Trade Game Free Bets Section. Free Bets shared would have a 1 day valid period. Remember to use it on time! -
Msport reserves the right to amend, cancel, reclaim, or refuse any promotion at its discretion. Msport general terms and conditions apply.
URL: https://www.msport.com/gh/promotion/trader_giveaway.html
NB: Users can click on the link below and this will redirect them to the guide page of the TRADE GAME
https://msportsupportgh.zendesk.com/hc/en-us/articles/31963995175959-TRADER-CASINO-GAME
Comments
0 comments
Article is closed for comments.